These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22740622)

  • 1. von Willebrand factor antigen--a possible biomarker of disease activity in childhood central nervous system vasculitis?
    Cellucci T; Tyrrell PN; Pullenayegum E; Benseler SM
    Rheumatology (Oxford); 2012 Oct; 51(10):1838-45. PubMed ID: 22740622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood primary angiitis of the central nervous system: identifying disease trajectories and early risk factors for persistently higher disease activity.
    Cellucci T; Tyrrell PN; Sheikh S; Benseler SM
    Arthritis Rheum; 2012 May; 64(5):1665-72. PubMed ID: 22544528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary central nervous system vasculitis in children.
    Benseler SM; Silverman E; Aviv RI; Schneider R; Armstrong D; Tyrrell PN; deVeber G
    Arthritis Rheum; 2006 Apr; 54(4):1291-7. PubMed ID: 16575852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system vasculitis in children.
    Cellucci T; Benseler SM
    Curr Opin Rheumatol; 2010 Sep; 22(5):590-7. PubMed ID: 20671523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood central nervous system vasculitis.
    Benseler S; Pohl D
    Handb Clin Neurol; 2013; 112():1065-78. PubMed ID: 23622312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood primary angiitis of the central nervous system.
    Malik MA; Zia-ur-Rehman M; Nadeem MM; Chaudhry FR; Qureshi AA; Nawaz M; Malik H
    J Coll Physicians Surg Pak; 2012 Sep; 22(9):570-4. PubMed ID: 22980610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor antigen as a marker of disease activity in childhood-onset antineutrophil cytoplasmic antibody-associated vasculitis.
    Go E; Aeschlimann FA; Lu H; Larry JR; Hebert D; Yeung RSM; Noone D
    Rheumatology (Oxford); 2024 Sep; 63(SI2):SI228-SI232. PubMed ID: 37963037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
    Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
    J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
    D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
    J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system vasculitis in children.
    Elbers J; Benseler SM
    Curr Opin Rheumatol; 2008 Jan; 20(1):47-54. PubMed ID: 18281857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement.
    Lippi G; Franchini M; Targher G; Poli G; Guidi GC
    Clin Chim Acta; 2007 Jun; 381(2):167-70. PubMed ID: 17433810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
    Castaman G; Tosetto A; Goodeve A; Federici AB; Lethagen S; Budde U; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Habart D; Hill F; Peake I; Rodeghiero F
    Br J Haematol; 2010 Nov; 151(3):245-51. PubMed ID: 20738304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnostic approach of the parents-children relationship in differentiating low-level von Willebrand factor from mild type 1 von Willebrand disease.
    Akin M
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):351-3. PubMed ID: 22450546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain biopsy in children with primary small-vessel central nervous system vasculitis.
    Elbers J; Halliday W; Hawkins C; Hutchinson C; Benseler SM
    Ann Neurol; 2010 Nov; 68(5):602-10. PubMed ID: 21031577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor, fibrinogen and other risk factors of thrombosis in patients with a history of cerebrovascular ischemic stroke and their children.
    Jastrzebska M; Torbus-Lisiecka B; Honczarenko K; Foltynska A; Chełstowski K; Naruszewicz M
    Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):132-40. PubMed ID: 12325470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory indicators of endothelial involvement in rheumatic diseases associated with vasculitis in children].
    Dolezalová P; Telekesová P; Nĕmcová D; Bĕlorová J; Kvasnicka J; Hoza J
    Cas Lek Cesk; 2003; 142(10):615-9. PubMed ID: 14635427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease--results based on an epidemiological investigation.
    Rodeghiero F; Castaman G; Tosetto A
    Thromb Haemost; 1990 Nov; 64(3):349-52. PubMed ID: 2096485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.